Version 5.4
Mus musculus Gene: Serpinb9f
Summary
InnateDB Gene IDBG-143239.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Serpinb9f
Gene Name serine (or cysteine) peptidase inhibitor, clade B, member 9f
Synonyms BC052216; NK21; NK21L1; ovalbumin; Spi13
Species Mus musculus
Ensembl Gene ENSMUSG00000038327
Encoded Proteins
IDBP-143241
serine (or cysteine) peptidase inhibitor, clade B, member 9f
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary Currently no Entrez Summary Available. You might want to check the Summary Sections of the Orthologs.
Gene Information
Type Protein coding
Genomic Location Chromosome 13:33324077-33335370
Strand Forward strand
Band A3.3
Transcripts
ENSMUST00000075515 ENSMUSP00000074958
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0004867 serine-type endopeptidase inhibitor activity
Biological Process
GO:0002244 hematopoietic progenitor cell differentiation
GO:0010951 negative regulation of endopeptidase activity
GO:0030162 regulation of proteolysis
Cellular Component
GO:0005615 extracellular space
GO:0005737 cytoplasm
Orthologs
No orthologs found for this gene
Pathways
NETPATH
REACTOME
KEGG
mmu05146
Amoebiasis pathway
INOH
PID NCI
Cross-References
SwissProt
TrEMBL O08805 Q80UK5
UniProt Splice Variant
Entrez Gene 20709
UniGene Mm.474264 Mm.490869
RefSeq NM_183197
OMIM
CCDS CCDS26436
HPRD
IMGT
MGI ID MGI:894671
MGI Symbol Serpinb9f
EMBL AC162928 BC052216 U96708
GenPept AAB57820 AAH52216
RNA Seq Atlas 20709

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca